Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 crossover PK study of naldemedine granules vs tablet and food effect in healthy adults
jRCT2080224678Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of naldemedine in opioid-induced constipation (OIC) (3 arms), sponsored by Shionogi & Co., Ltd. Started May 2019; status: completed.
02
Drugs
naldemedine
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on jRCT2080224678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224678.